Search Results - "Kransdorf, E."

Predictors of Delayed Renal Graft Function in Combined Heart and Kidney Transplant Recipients by Nguyen, V., Kransdorf, E., Patel, J., Nishihara, K., Levine, R., Sumbi, C., Kobashigawa, J.

“…Combined heart and kidney transplant has a protective effect on the cardiac graft. We set out to assess the impact of donor, recipient and transplant…”
Get full text

Heart Transplantation for Chagas Cardiomyopathy in the United States by Kransdorf, E. P., Czer, L. S. C., Luthringer, D. J., Patel, J. K., Montgomery, S. P., Velleca, A., Mirocha, J., Zakowski, P. C., Zabner, R., Gaultier, C. R., Qvarnstrom, Y., Benedict, T., Steurer, F., Bosserman, E., Paddock, C. D., Rafiei, M., Kobashigawa, J. A.

“…Since an initial case in 2006, we noted multiple patients undergoing heart transplantation (HTx) for Chagas cardiomyopathy (CC) at our transplant program. The…”
Get full text

Does Brain Death Related to Underlying Donor Disease Correlate with Adverse Outcomes after Heart Transplant? by Emerson, D., Megna, D., Cole, R., Levine, R., Esmailian, F., Chikwe, J., Trento, A., Ramzy, D., Kransdorf, E., Kobashigawa, J.

“…Donation after brain death is the primary method by which donor hearts become available within the U.S. It has been previously postulated that the method by…”
Get full text

Predictors of Renal Graft Failure in Heart/Kidney Transplant Recipients by Nguyen, V., Kransdorf, E., Patel, J., Kittleson, M., Chang, D., Czer, L., Kobashigawa, J.A.

“…Combined heart and kidney transplantation have a protective effect on the cardiac graft. Little is known about the factors that impact renal graft function…”
Get full text

Desensitization Therapy for Mechanical Circulatory Support Patients with Existing Driveline Infection: Is It Safe with Current Desensitization Therapies? by Kittleson, M., Patel, J., Kransdorf, E., Shen, A., Nishihara, K., Rajkumar, S., Velleca, A., Geft, D., Czer, L., Moriguchi, J., Kobashigawa, J.

“…Patients with end-stage heart failure may undergo mechanical circulatory support (MCS) as a bridge to transplant. This strategy may be complicated by…”
Get full text

The Natural History of Pre-Existing Donor Specific Antibody and Amnestic Responses after Heart Transplantation by Patel, J., Kittleson, M., Kransdorf, E., Chang, D., Czer, L., Shen, A., Nishihara, K., Sharoff, R., Hamilton, M., Esmailian, F., Kobashigawa, J.A.

“…Sensitized patients have prolonged wait times for heart transplant and often low-level donor specific antibodies (DSA) will be crossed when accepting a donor…”
Get full text

Outcome of Right Ventricular Primary Graft Dysfunction after Heart Transplantation by Kittleson, M., Patel, J., Chang, D., Kransdorf, E., Shen, A., Nishihara, K., Melamed, D., Jamero, G., Azarbal, B., Czer, L., Ramzy, D., Trento, A., Kobashigawa, J.

“…Primary graft dysfunction (PGD) is observed in approximately 7% of all heart transplant (HTx) patients (pts). According to the International Society for Heart…”
Get full text

Post-Heart Transplant Outcomes of Sensitized Patients Who Have Undergone Desensitization Therapy by Kobashigawa, J.A., Kittleson, M., Chang, D.H., Kransdorf, E., Shen, A., Nishihara, K., Jamero, G., Coleman, B., Czer, L., Ramzy, D., Esmailian, F., Patel, J.

“…Sensitized patients awaiting heart transplantation (HTx) are at increased risk for mortality as their waitlist time is lengthened due to incompatible donors…”
Get full text

Does the Development of Donor Specific Antibody after Heart Transplantation Depend on the Presence or Absence of Corticosteroids as Maintenance Therapy? by Patel, J., Kittleson, M., Kransdorf, E., Shen, A., Nishihara, K., Jamero, G., Azarbal, B., Hage, A., Czer, L., Megna, D., Kobashigawa, J.A.

“…The development of donor specific antibody (DSA) after heart transplantation has been associated with increased development of cardiac allograft vasculopathy…”
Get full text

Donor Specific Antibodies after Heart Transplantation: Can They Be Treated? by Aiken, A., Patel, J., Kransdorf, E., Shen, A., Nishihara, K., Velleca, A., Cole, R., Hamilton, M., Czer, L., Megna, D., Zhang, X., Kobashigawa, J.

“…The development of post-transplant donor specific antibody (DSA), especially those that bind complement (C1q+), has been associated with development of cardiac…”
Get full text

Is Anti-Thymocyte Globulin for Sensitized Patients Undergoing Heart Transplantation Effective? by Kittleson, M., Patel, J., Kransdorf, E., Shen, A., Nishihara, K., Jamero, G., Sana, S., Hage, A., Geft, D., Czer, L., Esmailian, F., Kobashigawa, J.A.

“…Anti-thymocyte globulin (ATG) has been used as an induction agent in heart transplant (HTx). Early studies suggest that ATG can decrease de novo donor specific…”
Get full text

Sarcopenia as a Predictor of Postoperative Hospital Stay in Heart Transplant Recipients by McGrath, B, Vucicevic, D, Kransdorf, E, Steidley, D, Pajaro, O, Carey, E

Get full text

Coronary Vasospasm After Heart Transplantation: Does It Portend Poor Outcome? by Chang, D, Kittleson, M, Patel, J, Aintablian, T, Rodriguez, G, Levine, R, Geft, D, Kransdorf, E, Czer, L, Esmailian, F, Kobashigawa, J.A

Get full text

Success for Combined Heart and Kidney Transplantation by Megna, D, Esmailian, F, Patel, J, Kittleson, M, Aintablian, T, Stimpson, E, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Kobashigawa, J.A

Get full text

Donor Heart Diastolic Dysfunction: Do You Take This Heart for Transplantation? by Liou, F, Kittleson, M, Patel, J, Aintablian, T, Kao, T, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Ramzy, D, Kobashigawa, J.A

Get full text

Treatment of Primary Graft Dysfunction with Plasmapheresis Improves Outcome by Chang, D.H, Kittleson, M, Patel, J, Aintablian, T, Levine, R, Geft, D, Kransdorf, E, Czer, L, Trento, A, Esmailian, F, Kobashigawa, J.A

Get full text

Only Persistent Donor Specific Antibodies are Associated with Subsequent Cardiac Allograft Vasculopathy After Heart Transplantation by Kobashigawa, J.A, Kittleson, M, Aintablian, T, Azarbal, B, Hage, A, Kransdorf, E, Geft, D, Chang, D, Czer, L, Esmailian, F, Zhang, X, Reinsmoen, N, Patel, J

Get full text

Is Tacrolimus/Proliferation Signal Inhibitor (PSI) Comparable to Cyclosporine/PSI After Heart Transplantation? by Chang, D, Kittleson, M, Patel, J, Aintablian, T, Velleca, A, Jamero, G, Kransdorf, E, Geft, D, Czer, L, Esmailian, F, Kobashigawa, J.A

Get full text

Does Socioeconomic Status Impact Outcome Following Mechanical Circulatory Support Device Implantation? by Chang, D.H, Kittleson, M, Patel, J, Aintablian, T, Hamilton, M, Geft, D, Kransdorf, E, Czer, L, Kobashigawa, J.A, Arabia, F, Moriguchi, J

Get full text

Combined Heart-Kidney Transplant vs Heart Alone Transplant in Patients with Total Artificial Heart: Are they Viable? by Moriguchi, J, Kittleson, M, Patel, J, Aintablian, T, Kwan, J, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Kobashigawa, J.A, Arabia, F

Get full text